D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma

This publication has 24 references indexed in Scilit:

• Kaposiform Hemangioendothelioma
  The American Journal of Surgical Pathology, 2004
• Kaposiform Hemangioendothelioma: Five Patients with Cutaneous Lesion and Long Follow-Up
  Laboratory Investigation, 2001
• Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas
  Laboratory Investigation, 2000
• Residual lesions after Kasabach-Merritt phenomenon in 41 patients☆, ☆☆
  Journal of the American Academy of Dermatology, 2000
• Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
  Cancer, 1999
• Vascular Endothelial Growth Factor-C A Growth Factor for Lymphatic and Blood Vascular Endothelial Cells
  Trends in Cardiovascular Medicine, 1998
• Kaposiform Hemangioendothelioma
  Archives of Dermatology, 1997
• Thrombocytopenic Coagulopathy (Kasabach-Merritt Phenomenon) Is Associated with Kaposiform Hemangioendothelioma and Not with Common Infantile Hemangioma
  Plastic and Reconstructive Surgery, 1997
• Kaposiform Hemangioendothelioma of Infancy and Childhood
  The American Journal of Surgical Pathology, 1993
• Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy
  New England Journal of Medicine, 1992